Drug distributor Cencora (NYSE:COR) agreed to repurchase shares of its common stock from Walgreens Boots Alliance (NASDAQ:WBA) for ~$50M in concurrence with Walgreens Boots Alliance’s sale of ...

Cencora, Inc. COR is well-poised for growth on the back of a robust U.S. Healthcare Solutions business and product launches.

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount ...

Cencora is attractively valued for potentially strong total returns. Plus, with Walgreens' equity stake in COR reduced to just 6%, COR has more freedom to chart its own course.

Cencora's fiscal year 2025 guidance does not currently include the impact of the RCA acquisition, which will be incorporated following the transaction's close. THE LARGER TREND. Walgreens Boots ...

Walgreens Boots Alliance Inc. (NASDAQ:WBA) is a leading global retail pharmacy and healthcare company. The stock is trading down 60% from its 52-week high and with a stock performance down 58.5% ...

Walgreens has embarked on a $1 billion cost-cutting program under CEO Tim WentworthTim Wentworth Business Wire. It currently employs 312,000 people in 12,000 stores in eight countries, according ...

Cencora, Inc. COR witnessed strong momentum in the year-to-date period. Shares of the company have rallied 14.7% compared with 2.8% growth of the industry. The S&P 500 Composite has risen 22.5% ...

Cencora, Inc. COR is well-poised for growth on the back of robust U.S. Healthcare Solutions business and product launches. However, intense competition is a concern. Shares of this Zacks Rank #2 ...